Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease

Krish Chandrasekaran, Kimmo Hatanpää, Daniel R. Brady, Stanley I. Rapoport

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

In vivo imaging of patients with Alzheimer's disease using positron emission tomography (PET) demonstrates progressive reductions in brain glucose metabolism and blood flow in relation to dementia severity, more so in association than primary cortical regions. These reductions likely follow regional synaptic loss or dysfunction and reflect physiological down-regulation of gene expression for glucose delivery, oxidative phosphorylation (OXPHOS), and energy consumption in brain. Indeed, the pattern of down-regulation of expression for both mitochondrial and nuclear genes coding for subunits of OXPHOS enzymes in the Alzheimer brain resembles the pattern of down-regulation in normal brain caused by chronic sensory deprivation. In both cases, down-regulation likely is mediated by changes in transcriptional and posttranscriptional regulatory factors. Physiological down-regulation of OXPHOS gene expression in Alzheimer's is consistent with PET evidence that cognitive or psychophysical activation of mildly to moderately demented Alzheimer's patients can augment brain-blood flow and glucose metabolism to the same extent as in control subjects. If the primary neuronal defect that leads to reduced brain energy demand in Alzheimer's disease could be prevented or treated, brain glucose transport and OXPHOS enzyme activities might recover to normal levels.

Original languageEnglish (US)
Pages (from-to)80-88
Number of pages9
JournalExperimental Neurology
Volume142
Issue number1
DOIs
StatePublished - Nov 1996

Fingerprint

Oxidative Phosphorylation
Alzheimer Disease
Down-Regulation
Brain
Positron-Emission Tomography
Blood Glucose
Sensory Deprivation
Glucose
Mitochondrial Genes
Gene Expression Regulation
Enzymes
Dementia
Gene Expression

ASJC Scopus subject areas

  • Neurology
  • Neuroscience(all)

Cite this

Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease. / Chandrasekaran, Krish; Hatanpää, Kimmo; Brady, Daniel R.; Rapoport, Stanley I.

In: Experimental Neurology, Vol. 142, No. 1, 11.1996, p. 80-88.

Research output: Contribution to journalArticle

Chandrasekaran, Krish ; Hatanpää, Kimmo ; Brady, Daniel R. ; Rapoport, Stanley I. / Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease. In: Experimental Neurology. 1996 ; Vol. 142, No. 1. pp. 80-88.
@article{a1cfd5892e364712830060465c3ce5ce,
title = "Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease",
abstract = "In vivo imaging of patients with Alzheimer's disease using positron emission tomography (PET) demonstrates progressive reductions in brain glucose metabolism and blood flow in relation to dementia severity, more so in association than primary cortical regions. These reductions likely follow regional synaptic loss or dysfunction and reflect physiological down-regulation of gene expression for glucose delivery, oxidative phosphorylation (OXPHOS), and energy consumption in brain. Indeed, the pattern of down-regulation of expression for both mitochondrial and nuclear genes coding for subunits of OXPHOS enzymes in the Alzheimer brain resembles the pattern of down-regulation in normal brain caused by chronic sensory deprivation. In both cases, down-regulation likely is mediated by changes in transcriptional and posttranscriptional regulatory factors. Physiological down-regulation of OXPHOS gene expression in Alzheimer's is consistent with PET evidence that cognitive or psychophysical activation of mildly to moderately demented Alzheimer's patients can augment brain-blood flow and glucose metabolism to the same extent as in control subjects. If the primary neuronal defect that leads to reduced brain energy demand in Alzheimer's disease could be prevented or treated, brain glucose transport and OXPHOS enzyme activities might recover to normal levels.",
author = "Krish Chandrasekaran and Kimmo Hatanp{\"a}{\"a} and Brady, {Daniel R.} and Rapoport, {Stanley I.}",
year = "1996",
month = "11",
doi = "10.1006/exnr.1996.0180",
language = "English (US)",
volume = "142",
pages = "80--88",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease

AU - Chandrasekaran, Krish

AU - Hatanpää, Kimmo

AU - Brady, Daniel R.

AU - Rapoport, Stanley I.

PY - 1996/11

Y1 - 1996/11

N2 - In vivo imaging of patients with Alzheimer's disease using positron emission tomography (PET) demonstrates progressive reductions in brain glucose metabolism and blood flow in relation to dementia severity, more so in association than primary cortical regions. These reductions likely follow regional synaptic loss or dysfunction and reflect physiological down-regulation of gene expression for glucose delivery, oxidative phosphorylation (OXPHOS), and energy consumption in brain. Indeed, the pattern of down-regulation of expression for both mitochondrial and nuclear genes coding for subunits of OXPHOS enzymes in the Alzheimer brain resembles the pattern of down-regulation in normal brain caused by chronic sensory deprivation. In both cases, down-regulation likely is mediated by changes in transcriptional and posttranscriptional regulatory factors. Physiological down-regulation of OXPHOS gene expression in Alzheimer's is consistent with PET evidence that cognitive or psychophysical activation of mildly to moderately demented Alzheimer's patients can augment brain-blood flow and glucose metabolism to the same extent as in control subjects. If the primary neuronal defect that leads to reduced brain energy demand in Alzheimer's disease could be prevented or treated, brain glucose transport and OXPHOS enzyme activities might recover to normal levels.

AB - In vivo imaging of patients with Alzheimer's disease using positron emission tomography (PET) demonstrates progressive reductions in brain glucose metabolism and blood flow in relation to dementia severity, more so in association than primary cortical regions. These reductions likely follow regional synaptic loss or dysfunction and reflect physiological down-regulation of gene expression for glucose delivery, oxidative phosphorylation (OXPHOS), and energy consumption in brain. Indeed, the pattern of down-regulation of expression for both mitochondrial and nuclear genes coding for subunits of OXPHOS enzymes in the Alzheimer brain resembles the pattern of down-regulation in normal brain caused by chronic sensory deprivation. In both cases, down-regulation likely is mediated by changes in transcriptional and posttranscriptional regulatory factors. Physiological down-regulation of OXPHOS gene expression in Alzheimer's is consistent with PET evidence that cognitive or psychophysical activation of mildly to moderately demented Alzheimer's patients can augment brain-blood flow and glucose metabolism to the same extent as in control subjects. If the primary neuronal defect that leads to reduced brain energy demand in Alzheimer's disease could be prevented or treated, brain glucose transport and OXPHOS enzyme activities might recover to normal levels.

UR - http://www.scopus.com/inward/record.url?scp=0030296713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030296713&partnerID=8YFLogxK

U2 - 10.1006/exnr.1996.0180

DO - 10.1006/exnr.1996.0180

M3 - Article

C2 - 8912900

AN - SCOPUS:0030296713

VL - 142

SP - 80

EP - 88

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 1

ER -